Caricamento...
Promising response to axitinib rechallenge for metastatic renal cell carcinoma after progression on prior axitinib: report of two cases
With the marked improvement in the prognosis of patients with metastatic renal cell carcinoma (mRCC) in the era of molecularly targeted therapy, sequential therapies using multiple targeted agents have been intensively performed for these patients. Despite being conducted targeting small cohorts, se...
Salvato in:
| Pubblicato in: | Int Cancer Conf J |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer Japan
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6498296/ https://ncbi.nlm.nih.gov/pubmed/31149509 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-017-0313-y |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|